SCHEMBL7780326

SCHEMBL7780326

NS(=O)(=O)c1ccc(-c2nn(Cc3ccccc3)c(C(F)F)c2-c2ccc(Cl)cc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 10/20 0.47
PTGS1 P23219 6/20 0.47
HTR7 P34969 2/20 0.45
HTR1A P08908 1/20 0.45
HTR2A P28223 1/20 0.45
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
ALDH1A1 P00352 1/20 0.41
LMNA P02545 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
HTT P42858 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
CA12 O43570 4/20 0.41
CA1 P00915 4/20 0.41
CA2 P00918 4/20 0.41
CA9 Q16790 4/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7779970 0.91 PTGS2 (0.48) PTGS2PTGS1MEN1KMT2ACA12
SCHEMBL7779503 0.91 PTGS2 (0.48) PTGS2PTGS1LMNACYP3A4CYP2D6
SCHEMBL7779999 0.89 PTGS2 (0.51) PTGS2PTGS1HTR7HTR1AHTR2A
SCHEMBL7779799 0.86 PTGS2 (0.55) PTGS2PTGS1CA12CA1CA2
SCHEMBL8631831 0.85 HTR7 (0.39) PTGS2PTGS1HTR7HTR1AHTR2A
SCHEMBL7780584 0.84 PTGS2 (0.48) PTGS2PTGS1HTR7HTR1AHTR2A
SCHEMBL7778025 0.83 PTGS2 (0.47) PTGS2PTGS1CA12CA1CA2
SCHEMBL7779672 0.83 PTGS2 (0.61) PTGS2PTGS1HTR7HTR1AHTR2A
SCHEMBL7779823 0.83 PTGS2 (0.47) PTGS2PTGS1CA12CA1CA2
SCHEMBL7779765 0.82 PTGS2 (0.53) PTGS2PTGS1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0772597-B1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2001-12-12 EP disclosed
EP-1127878-A1 3,4 - substituted pyrazoles for the treatment of inflammation G.D. SEARLE & CO. (US) 2001-08-29 EP disclosed
US-6028072-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 2000-02-22 US disclosed
EP-0772597-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-05-14 EP disclosed
US-5580985-A ANTIARTHRITIC AGENT; SIDE EFFECT REDUCTION G. D. SEARLE & CO. (US) 1996-12-03 US disclosed
WO-1996003385-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-02-08 WO disclosed
US-5486534-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 1996-01-23 US disclosed